Rockwell Medical (RMTI) Share-based Compensation (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Share-based Compensation came in at $479000.0 in Q1 2026, down 52.39% on a QoQ basis from $1.0 million in Q2 2025.
Rockwell Medical (RMTI) Share-based Compensation (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Share-based Compensation data on file, last reported at $479000.0 in Q1 2026.
- Quarterly Share-based Compensation changed N/A year-over-year to $479000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 15.67% YoY) and the FY2025 annual result came in at $1.0 million, down 50.0% from the prior year.
- Share-based Compensation fell to $479000.0 in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.5 million in Q1 2024 to a low of -$193000.0 in Q2 2023.
- A 5-year average of $428071.4 and a median of $219000.0 in 2022 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation plunged 298.97% — and 2024, when it surged 772.54%.
- Tracing RMTI's Share-based Compensation over 5 years: stood at $220000.0 in 2022, then fell by 0.91% to $218000.0 in 2023, then plunged by 87.16% to $28000.0 in 2024, then jumped by 3492.86% to $1.0 million in 2025, then sank by 52.39% to $479000.0 in 2026.
- The last three Share-based Compensation figures came in at $479000.0 (Q1 2026), $1.0 million (Q2 2025), and $28000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Rockwell Medical | 29.77 Mn | 4.98 Mn | 3.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 479,000.00 |
| Mar 31, 2026 | 479,000.00 |
| Jun 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Dec 31, 2024 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 435,000.00 |
| Sep 30, 2024 | 435,000.00 |
| Jun 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 218,000.00 |
| Dec 31, 2023 | 218,000.00 |
| Sep 30, 2023 | 714,000.00 |
| Sep 30, 2023 | 714,000.00 |
| Jun 30, 2023 | -193,000.00 |
| Jun 30, 2023 | -193,000.00 |
| Mar 31, 2023 | 193,000.00 |
| Mar 31, 2023 | 193,000.00 |